US Warrant News

Fannie And Freddie: Elegant Solutions After Imprudent ActionsSeeking Alpha (registration)The FHFA will declare that the Senior Preferred stock is paid back and direct the GSEs to stop transferring their net worth to the Treasury. This eliminates the tremendous cost of paying back the bailout and begins to unlock the value for common … …read more

Cytori Therapeutics, Inc. Announces Closing of FinancingMarketWatchThe preferred stock is convertible into shares of Cytori’s common stock at the option of the investors at a conversion price of $0.52. Cytori also issued warrants to purchase an aggregate of 25,961,541 shares of Cytori’s common stock at an exercise … and more …read more

Challenger Announces Closing of Private PlacementSYS-CON Media (press release)Assuming the exercise of the warrants and stock options in full, Mr. Sundher would beneficially own or control an aggregate of 15,117,496 common shares of the Company, representing approximately 24.73% of the issued and outstanding common shares of … and more …read more

Challenger Announces Closing of Private PlacementMarketWatchAssuming the exercise of the warrants and stock options in full, Mr. Sundher would beneficially own or control an aggregate of 15,117,496 common shares of the Company, representing approximately 24.73% of the issued and outstanding common shares of … and more …read more

Synthetic Biologics to Raise $20.7 Million in Registered Direct OfferingFierceBiotechEach unit consists of one share of the Company’s common stock and a warrant to purchase 0.5 shares of the Company’s common stock at an exercise price of $1.75 per share, which represents approximately a 25% premium to the Company’s closing stock price …Synthetic Biologics To

Synthetic Biologics To Raise About $20.7 Mln In Registered Direct OfferingNASDAQEach unit consists of one share of the company’s common stock and a warrant to purchase 0.5 shares of its common stock at an exercise price of $1.75 per share, which represents approximately a 25% premium to its closing stock price on October 9. These

Synthetic Biologics (SYN) Enters $20.7M Direct Offering at $1.47/UnitStreetInsider.com (subscription)Each unit consists of one share of the Company’s common stock and a warrant to purchase 0.5 shares of the Company’s common stock at an exercise price of $1.75 per share, which represents approximately a 25% premium to the Company’s closing stock price …Synthetic Biologics To